New-York News

FDA panel votes against MDMA for PTSD, setting up hurdle to approval

[ad_1]

FDA advisers cited a variety of concerns with the trials submitted by Lykos Therapeutics as part of the application.

[ad_2]

, 2024-06-04 23:53:33

Source link

Related posts

Vacation horror as ‘drunk’ son, 20, jumps from Royal Caribbean cruise in front of family

New-York

How compassion, not just free tuition, helped one Ohio student achieve his college dreams

New-York

U.S. and Saudi Arabia near potentially historic security deal

New-York

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy